Regulatory Coordinator

Full course · The Regulatory Coordinator: Role, Scope & Professional Identity

The regulatory landscape from the site's chair: ICH, FDA, IRB/IEC, and sponsor requirements converging on your desk — The Regulatory Coordinator: Role, Scope & Professional Identity

The regulatory landscape from the site's chair: ICH, FDA, IRB/IEC, and sponsor requirements converging on your desk

Examines how multiple regulatory frameworks generate overlapping and sometimes conflicting obligations at the site level, and how the RC reconciles them

20 min

Three versions of the same form

A sponsor sends a monitoring visit letter requesting an updated delegation log. The log must reflect the format in the sponsor's study-specific procedure: a proprietary template with 14 columns, electronic signatures, and a revision history footer. Straightforward enough. But the site's IRB requires its own delegation log format for continuing review submissions -- eight columns, wet-ink signatures, and a certification statement at the bottom that the sponsor's template does not include. And then the site's institutional policy, driven by the compliance office's interpretation of 21 CFR 312.62, mandates a third format: one that captures FTE percentages and links each delegated task to the staff member's documented training.

Three regulatory sources. Three versions of what is, conceptually, the same document. None of them is wrong. All of them are binding on the site -- through contract, through institutional policy, through federal regulation. And the person who must reconcile them, maintain them, and produce the correct version for the correct audience at the correct time is sitting at the regulatory coordinator's desk.

The previous two lessons established what the site's regulatory obligations are and why they demand systems-level infrastructure at portfolio scale. This lesson asks a question that those lessons deferred: whose requirements, exactly, is the site fulfilling? Because the answer is not singular. It is layered, sometimes harmonious, occasionally contradictory, and always converging on the same desk.

What you will learn3 objectives

By the end of this lesson, you will be able to:

Analyze how ICH E6(R3), FDA regulations (21 CFR Parts 50, 56, 312), and IRB/IEC policies create layered obligations at the investigator site, identifying areas of overlap, complement, and tension
Evaluate scenarios where sponsor SOPs impose requirements beyond E6(R3), determining which are obligatory and which are negotiable
Construct a decision framework for resolving conflicting regulatory guidance at the site level, applying the hierarchy of applicable law, ICH principles, and contractual agreements

Progress saves itself — finish reading and this lesson completes

Continue with the Regulatory Coordinator track

Three versions of the same form